1
项与 TP53 R248Q TCR-T Cell(Shanghai General Hospital) 相关的临床试验Early Clinical Study to Evaluate the Safety and Efficacy of TP53 R248Q Mutation-specific TCR-T Cell Therapy for Advanced Solid Tumor
To evaluate the safety and efficacy of T cell therapy with mutated TP53 R248Q specific TCR transduction in patients with advanced solid tumor expressing the TP53 R248Q mutation and the HLA-A*11:01 allele.
100 项与 TP53 R248Q TCR-T Cell(Shanghai General Hospital) 相关的临床结果
100 项与 TP53 R248Q TCR-T Cell(Shanghai General Hospital) 相关的转化医学
100 项与 TP53 R248Q TCR-T Cell(Shanghai General Hospital) 相关的专利（医药）
100 项与 TP53 R248Q TCR-T Cell(Shanghai General Hospital) 相关的药物交易
